FDA Proposes to Eliminate Adequate Provision Standard for DTC Broadcast Advertising

The proposed rule would significantly impact manufacturers of prescription drugs. The Food and Drug Administration (FDA) has signaled its next major step in the Trump administration’s ongoing crackdown on direct-to consumer (DTC) prescription drug advertising….
By: Latham & Watkins LLP